Revelation Pharma, a prominent national network of 503A and 503B compounding pharmacies, announced that its Postgraduate Year One Community-Based Pharmacy Residency Program has earned the maximum 8-year accreditation from the American Society of Health-System Pharmacists in partnership with the American Pharmacists Association. This achievement makes Revelation Pharma – Innovation Compounding the first compounding pharmacy in the country to receive the full 8-year ASHP accreditation for a PGY1 community-based residency program, highlighting the company’s dedication to advancing education, clinical excellence, and innovation in pharmacy compounding.
Health Technology Insights: Health Technology Insights: Latest News And Innovations – Roundup 4 November 2025
Shawn Hodges, PharmD and CEO of Revelation Pharma, emphasized that the residency program was designed to connect advanced compounding practice with clinical pharmacy in a way that provides a unique, hands-on learning experience. He stated that this recognition validates the importance of specialized training in compounding and reflects the company’s commitment to preparing the next generation of pharmacists to meet evolving patient care needs.
Health Technology Insights: Mirum Pharma showcases LIVMARLI and Volixibat data at AASLD
The PGY1 program offers residents extensive practical experience across sterile and non-sterile compounding, quality assurance, regulatory compliance, business operations, and personalized medication management. Residents gain exposure to diverse areas of patient care, including ambulatory care, dermatology, hormone therapy, pain management, and nutritional wellness, through Revelation Pharma’s national network of pharmacies and patient care partners.
Brandon Sucher, PharmD and Residency Program Director, noted that ASHP’s guidance and accreditation process provided a valuable roadmap for developing a robust and sustainable program. He said that achieving the 8-year accreditation demonstrates the strength of the residency program and reflects the hard work and dedication of the preceptors, leadership team, and residents who uphold high standards in patient care and pharmacy education.
Revelation Pharma continues to set a benchmark in compounding pharmacy by combining education, innovation, and collaboration to advance the profession and enhance patient outcomes across the nation.
Health Technology Insights: Gilead’s Livdelzi Shows ALP Reduction and Itch Relief in PBC
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com
